Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organigram Global Inc. (OGI : NSDQ)

• Company Description    Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO. Number of Employees: 1,139

• Price / Volume Information    Yesterday's Closing Price: $1.09 Daily Weekly Monthly 20 Day Moving Average: 1,049,259 shares Shares Outstanding: 140.77 (millions) Market Capitalization: $153.44 (millions) Beta: 1.50 52 Week High: $2.24 52 Week Low: $1.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.29% -32.69% 12 Week -24.83% -31.24% Year To Date -35.12% -40.79%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1400-145 King Street West - Toronto,A6 M5H 1J8 CAN ph: 1-844-644-4726 fax: - None http://www.organigram.ca

• General Corporate Information    Officers Beena Goldenberg - Chief Executive Officer Peter Amirault - Chairman Greg Guyatt - Chief Financial Officer Nathalie Batten Kubrick - Senior Vice President of Operations Max Schwartz - Director Peer Information Organigram Global Inc. (BJCT) Organigram Global Inc. (CADMQ) Organigram Global Inc. (APNO) Organigram Global Inc. (UPDC) Organigram Global Inc. (IMTIQ) Organigram Global Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 68617J100 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 140.77 Most Recent Split Date: 7.00 (0.25:1) Beta: 1.50 Market Capitalization: $153.44 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.09 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: 12.82 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.57 Price/Cash Flow: - Price / Sales: 0.78 EPS Growth vs. Year Ago Period: 80.00% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: -4.60% vs. Previous Quarter: -4.36% ROE 03/31/26 - -13.41 12/31/25 - -15.41 09/30/25 - -16.91 ROA 03/31/26 - -9.09 12/31/25 - -10.49 09/30/25 - -11.43 Current Ratio 03/31/26 - 2.82 12/31/25 - 2.73 09/30/25 - 2.26 Quick Ratio 03/31/26 - - 12/31/25 - 1.32 09/30/25 - 1.28 Operating Margin 03/31/26 - -18.09 12/31/25 - -20.59 09/30/25 - -23.66 Net Margin 03/31/26 - -9.22 12/31/25 - 6.03 09/30/25 - -9.99 Pre-Tax Margin 03/31/26 - -13.68 12/31/25 - 1.59 09/30/25 - -14.86 Book Value 03/31/26 - 1.93 12/31/25 - 1.96 09/30/25 - 1.86 Inventory Turnover 03/31/26 - 1.37 12/31/25 - 1.46 09/30/25 - 1.45 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 12.58 12/31/25 - 12.96 09/30/25 - 16.43

Powered by Zacks Investment Research ©